• Explore /
  • Poster
  • / Pazopanib in patients (pts) with advanced germ cell tumors (GCT): Results from an open-label, single-group, phase 2 trial (Pazotest-01).

Pazopanib in patients (pts) with advanced germ cell tumors (GCT): Results from an open-label, single-group, phase 2 trial (Pazotest-01).

Abstract Poster

Authors

Andrea Necchi

Andrea Necchi

Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy

Andrea Necchi , Daniele Raggi , Patrizia Giannatempo , Giuseppina Calareso , Elena Togliardi , Nicola Nicolai , Flavio Crippa , Luigi Mariani , Roberto Salvioni

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Penile, Urethral, and Testicular Cancers

Clinical Trial Registration Number

NCT01743482

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 481)

DOI

10.1200/jco.2016.34.2_suppl.481

Abstract #

481

Poster Bd #

L6

Abstract Disclosures

Similar Posters

First Author: Patrizia Giannatempo

First Author: Andrea Necchi

First Author: Ugo De Giorgi

First Author: Daniele Raggi